Table 1 The characteristics of all 102 included patients

Total patients

102

Median age (range) years

59 (26–80)

BRCA1/2 status

BRCA WT

73 (71.6)

gBRCA1

22 (21.6)

gBRCA2

7 (6.9)

Primary site

Ovary

91 (89.2)

Fallopian tube

8 (7.8)

Primary peritoneal

3 (2.9)

Histological subtype

Serous

96 (94.1)

Mucinous

3 (2.9)

Clear cell

2 (2.0)

other

1 (1.0)

Stage at diagnosis

I

4 (3.9)

II

5 (4.9)

III

69 (67.7)

IV

23 (22.5)

Unknown

1 (1.0)

Timing of surgery

Primary

42 (41.2)

Interval

60 (58.8)

Surgical outcome

R0

85 (83.3)

R1

16 (15.7)

Not optimal

1 (1.0)

Lines of maintenance treatment before PARPi

1

46 (45.1)

2

39 (38.2)

≥ 3

17 (16.7)

PARPi used

Olaparib

62 (60.8)

Niraparib

35 (34.3)

other

5 (4.9)